35 results
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... PO (or 400 mg IV ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Preventing ... to 5 mg/kg/day IV ... Penicilliosis #IDSA
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for Preventing ... Clinical Disease ... clinical manifestation ... Trypanosomiasis #IDSA
Acute ED Migraine Therapy and Preventative Therapy Algorithm:
Acute migraine
 • IV NS IL bolus then infusion
Preventative Therapy Algorithm ... Acute migraine • IV ... • Ketorolac IV ... Migraine #management #algorithm ... #treatment #prevention
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... neutropenia < 7 days and clinically ... >7 days or • Clinically ... neutropenic #fever #IDSA ... #Algorithm #Management
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Fatigue and IBD Algorithm ... fatigue despite clinical ... IBD Pearls: • IDA ... and active IBD: IV ... IV FE formulations
Emergency Management of Hyperkalemia in Adults
Assess Patient - Airway Breathing Circulation Disability Exposure (ABCDE) Approach
 •
Treatment guided by clinical ... Calcium Gluconate IV ... Insulin–Glucose IV ... blood glucose Prevention ... Hyperkalemia #management #algorithm
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... stibogluconate) 20 mg/kg IV ... Leishmaniasis #Prevention
IV fluid for adults 
Resuscitation,  maintenance,  replacement. 
#clinical #management #algorithm
IV fluid for adults ... #clinical #management ... #algorithm